Clinic
Upmc Williamsport
Upmc Williamsport was paid $9.69M by Medicaid between Oct 2019 and Dec 2024, across 169 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoUPMC WILLIAMSPORT
WILLIAMSPORT, PA 17701
WILLIAMSPORT, PA 17701
33aNPI1609801976assigned 07/12/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$9.69M
24GClaims317,269
24DCodes billed169
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Pennsylvania
Rank by total paid#4 of 119
Median peer was paid$57K
This provider vs. median169×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 580 | $49K | |
| 2020 | 24,784 | $701K | |
| 2021 | 106,973 | $3.13M | |
| 2022 | 57,223 | $1.67M | |
| 2023 | 72,707 | $2.29M | |
| 2024incomplete | 55,002 | $1.86M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 32,724 | 31,086 | $3.00M |
| G0378 | Hospital observation service, per hour | 15% | 2,876 | 1,518 | $1.45M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 19,138 | 18,353 | $1.21M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 8,813 | 8,345 | $952K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 2,441 | 2,365 | $384K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 14,723 | 13,916 | $348K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.4% | 550 | 537 | $235K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 3,433 | 3,060 | $180K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 8,829 | 8,072 | $151K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 1,241 | 520 | $150K |
| 80053 | Comprehensive metabolic panel | 1.4% | 14,436 | 13,574 | $136K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 28,845 | 26,042 | $135K |
157 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 2,371 | $133K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 861 | $105K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 12,105 | $104K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 13,950 | $97K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 987 | $72K |
| 84484 | <1% | 8,452 | $68K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 384 | $62K |
| 84703 | <1% | 5,380 | $53K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,477 | $41K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 643 | $41K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 2,081 | $34K |
| 83690 | <1% | 8,010 | $34K | |
| 81001 | <1% | 13,067 | $31K | |
| 83605 | <1% | 4,239 | $29K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,088 | $26K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 440 | $25K |
| 85730 | <1% | 4,346 | $22K | |
| 83735 | <1% | 4,377 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,308 | $21K |
| 83880 | <1% | 993 | $21K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,032 | $21K |
| 80076 | <1% | 2,980 | $19K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,876 | $19K |
| 93971 | <1% | 309 | $17K | |
| 85610 | <1% | 5,931 | $17K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 531 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 385 | $11K |
| 71250 | <1% | 213 | $10K | |
| 80329 | <1% | 744 | $9K | |
| 76830 | Ultrasound, transvaginal | <1% | 182 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 528 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,754 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 537 | $7K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 920 | $7K |
| 87040 | <1% | 518 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 18 | $7K |
| 73564 | <1% | 341 | $6K | |
| 82803 | <1% | 355 | $6K | |
| 84702 | <1% | 378 | $6K | |
| 90715 | <1% | 729 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,656 | $5K |
| 73610 | <1% | 375 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 254 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 255 | $5K |
| 80050 | General health panel | <1% | 124 | $5K |
| 70486 | <1% | 74 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,295 | $4K |
| 73130 | <1% | 375 | $4K | |
| 87077 | <1% | 763 | $3K | |
| 87186 | <1% | 648 | $3K | |
| 73630 | <1% | 398 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 55 | $3K |
| 93970 | <1% | 45 | $3K | |
| 86850 | <1% | 488 | $3K | |
| 73030 | <1% | 270 | $3K | |
| J3490 | Unclassified drugs | <1% | 1,087 | $2K |
| 87081 | <1% | 516 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 31 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 130 | $2K |
| 73110 | <1% | 198 | $2K | |
| 82330 | <1% | 323 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,019 | $2K |
| 86901 | <1% | 566 | $2K | |
| 86900 | <1% | 566 | $2K | |
| J1815 | Injection, insulin, per 5 units | <1% | 333 | $2K |
| 85379 | <1% | 199 | $2K | |
| 85027 | <1% | 673 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 77 | $1K |
| 80061 | Lipid panel | <1% | 295 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,527 | $1K |
| 70498 | <1% | 13 | $1K | |
| 82962 | <1% | 1,392 | $1K | |
| 82550 | <1% | 260 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 32 | $1K |
| 74018 | <1% | 138 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 65 | $1K |
| 70496 | <1% | 12 | $1K | |
| 82375 | <1% | 298 | $1K | |
| 72100 | <1% | 95 | $967.50 | |
| 73502 | <1% | 122 | $944.18 | |
| 86140 | <1% | 416 | $904.12 | |
| 72131 | <1% | 14 | $881.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,625 | $810.14 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 602 | $733.29 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 68 | $686.40 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 75 | $613.74 |
| 83050 | <1% | 298 | $553.86 | |
| 85652 | <1% | 251 | $480.54 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,655 | $474.98 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 534 | $444.78 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,888 | $443.21 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 65 | $437.87 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,768 | $422.72 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 294 | $406.11 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 269 | $402.54 |
| 73590 | <1% | 45 | $401.60 | |
| 84100 | <1% | 226 | $375.36 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 58 | $368.27 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,823 | $366.12 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,357 | $347.12 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 82 | $280.48 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 890 | $261.13 |
| 87210 | <1% | 46 | $260.08 | |
| 82947 | <1% | 186 | $246.71 | |
| 81025 | <1% | 106 | $244.58 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,767 | $220.53 |
| 85018 | <1% | 263 | $207.10 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 567 | $203.51 |
| 87070 | <1% | 81 | $195.37 | |
| 94644 | <1% | 16 | $182.67 | |
| 86618 | <1% | 12 | $181.23 | |
| 84145 | <1% | 13 | $173.23 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 413 | $168.88 |
| 76937 | <1% | 49 | $166.32 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $163.44 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 297 | $163.09 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,846 | $152.96 |
| 97162 | <1% | 40 | $152.66 | |
| 81003 | <1% | 57 | $143.24 | |
| 87205 | <1% | 70 | $116.75 | |
| 73080 | <1% | 12 | $116.15 | |
| 96367 | <1% | 54 | $115.03 | |
| 87430 | <1% | 12 | $114.16 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 170 | $107.47 |
| 97165 | <1% | 25 | $95.30 | |
| 87400 | <1% | 14 | $81.00 | |
| 84439 | <1% | 28 | $80.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 456 | $77.41 |
| 73562 | <1% | 13 | $75.90 | |
| 82140 | <1% | 28 | $47.47 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 238 | $44.26 |
| 84550 | <1% | 12 | $40.54 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 51 | $38.48 |
| S0028 | Injection, famotidine, 20 mg | <1% | 117 | $37.18 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 891 | $36.15 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 82 | $35.46 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 71 | $21.32 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,018 | $21.31 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $7.86 |
| 94760 | <1% | 53 | $5.33 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 160 | $4.62 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 17 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 26 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 79 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 2,165 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 17 | $0.00 |
| 88342 | 0% | 29 | $0.00 | |
| 96376 | 0% | 119 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
| 93922 | 0% | 18 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 31 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 20 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 0% | 49 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 18 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 31 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 23 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOST, ROGER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upmc Williamsport | Williamsport, PA | $4.00M |
| Charles Cole Memorial Hospital | Coudersport, PA | $3.64M |
| Upmc Lock Haven | Lock Haven, PA | $1.17M |
| Upmc Muncy | Muncy, PA | $1.04M |
| Cole Care, INC. | Coudersport, PA | $290K |
| Upmc Muncy | Muncy, PA | $37K |
| Upmc Muncy | Muncy, PA | $185.83 |
| Charles Cole Memorial D/B/A Upmc Cole | Coudersport, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.